-
01:28
1.
index 1
-
03:41
2.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
-
00:07
3.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
-
01:51
4.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
-
03:54
5.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
-
00:33
6.
CircRNA-SORE was critical for maintaining sorafenib resistance
-
02:43
7.
CircRNA-SORE was critical for maintaining sorafenib resistance
-
02:24
8.
CircRNA-SORE was critical for maintaining sorafenib resistance
-
01:22
9.
CircRNA-SORE was critical for maintaining sorafenib resistance
-
00:04
10.
CircRNA-SORE functioned by binding to YBX1 protein
-
00:12
11.
CircRNA-SORE was critical for maintaining sorafenib resistance
-
04:52
12.
CircRNA-SORE functioned by binding to YBX1 protein
-
04:35
13.
CircRNA-SORE functioned by binding to YBX1 protein
-
02:46
14.
CircRNA-SORE functioned by binding to YBX1 protein
-
02:03
15.
CircRNA-SORE functioned by binding to YBX1 protein
-
00:32
16.
CircRNA-SORE functioned by binding to YBX1 protein
-
00:04
17.
CircRNA-SORE functioned by binding to YBX1 protein
-
00:36
18.
CircRNA-SORE functioned by binding to YBX1 protein
-
08:48
19.
Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
-
04:23
20.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
-
00:50
21.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
-
02:42
22.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
-
01:14
23.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
-
02:47
24.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
-
04:29
25.
CircRNA-SORE transmited sorafenib resistance by exosomes
-
05:58
26.
CircRNA-SORE transmited sorafenib resistance by exosomes
-
00:15
27.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:01
28.
CircRNA-SORE transmited sorafenib resistance by exosomes
-
00:19
29.
** after 20221121.pptx
-
00:31
30.
CircRNA-SORE transmited sorafenib resistance by exosomes
-
00:02
31.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:04
32.
** after 20221121.pptx
-
02:05
33.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:15
34.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:35
35.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:08
36.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:03
37.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:05
38.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
02:20
39.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
00:10
40.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
-
04:42
41.
Conclusion
-
00:02
42.
** after 20221121.pptx